The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2015

Filed:

Aug. 25, 2006
Applicants:

John Fraser, Woodinville, WA (US);

Jeffry E. Powers, Bainbridge Island, WA (US);

Michalakis Averkiou, Nicosia, CY;

Inventors:

John Fraser, Woodinville, WA (US);

Jeffry E. Powers, Bainbridge Island, WA (US);

Michalakis Averkiou, Nicosia, CY;

Assignee:

Koninklijke Philips N.V., Eindhoven, NL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 8/00 (2006.01); A61B 8/12 (2006.01); A61B 17/22 (2006.01); A61B 8/08 (2006.01); A61B 8/14 (2006.01); A61B 17/225 (2006.01); G01S 15/89 (2006.01); A61B 19/00 (2006.01);
U.S. Cl.
CPC ...
A61B 17/22004 (2013.01); A61B 8/0833 (2013.01); A61B 8/14 (2013.01); A61B 8/481 (2013.01); A61B 17/2256 (2013.01); G01S 15/8918 (2013.01); G01S 15/8977 (2013.01); A61B 8/4405 (2013.01); A61B 2017/22028 (2013.01); A61B 2019/5276 (2013.01);
Abstract

A combined ultrasound imaging and therapy transducer () includes a linear array of imaging transducer elements (). First and second linear arrays of therapy transducer elements () extend longitudinally along respective first and second sides of the imaging transducer elements and are canted inwardly toward each other. The imaging and therapy transducer is used with an ultrasound imaging system to locate clots in a region of interest. After the region of interest has been perfused with a microbubble contrast agent, the therapy transducer elements are driven by an amplifier located in the transducer to dissolve the clot. The use of the imaging transducer elements and the therapy transducer elements can be interleaved so that the therapy can be conditioned on an ultrasound image showing substantial destruction of the contrast agent microbubbles, re-perfusion of microbubbles in the region of interest, or the continued presence of the clot.


Find Patent Forward Citations

Loading…